Capstone Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $677K | Buy |
7,458
+190
| +3% | +$17.2K | 0.02% | 744 |
|
|
2017
Q1 | $638K | Buy |
7,268
+1,150
| +19% | +$101K | 0.02% | 774 |
|
|
2016
Q4 | $507K | Buy |
6,118
+750
| +14% | +$62.2K | 0.01% | 923 |
|
|
2016
Q3 | $497K | Sell |
5,368
-341
| -6% | -$31.6K | 0.01% | 964 |
|
|
2016
Q2 | $444K | Buy |
5,709
+501
| +10% | +$39K | 0.01% | 1009 |
|
|
2016
Q1 | $430K | Buy |
5,208
+230
| +5% | +$19K | 0.01% | 1018 |
|
|
2015
Q4 | $521K | Buy |
4,978
+430
| +9% | +$45K | 0.02% | 893 |
|
|
2015
Q3 | $479K | Buy |
4,548
+770
| +20% | +$81.1K | 0.01% | 940 |
|
|
2015
Q2 | $517K | Sell |
3,778
-60
| -2% | -$8.21K | 0.01% | 946 |
|
|
2015
Q1 | $478K | Sell |
3,838
-50
| -1% | -$6.23K | 0.01% | 1108 |
|
|
2014
Q4 | $351K | Sell |
3,888
-210
| -5% | -$19K | 0.01% | 1278 |
|
|
2014
Q3 | $296K | Hold |
4,098
| – | – | 0.01% | 1366 |
|
|
2014
Q2 | $255K | Sell |
4,098
-1,465
| -26% | -$91.2K | 0.01% | 1478 |
|
|
2014
Q1 | $379K | Sell |
5,563
-1,290
| -19% | -$87.9K | 0.01% | 1265 |
|
|
2013
Q4 | $482K | Sell |
6,853
-8,272
| -55% | -$582K | 0.01% | 1159 |
|
|
2013
Q3 | $1.09M | Buy |
15,125
+850
| +6% | +$61.4K | 0.03% | 713 |
|
|
2013
Q2 | $796K | Buy |
+14,275
| New | +$796K | 0.02% | 848 |
|